In October 2022, the Personalised Cancer Care Alliance produced a position paper to advocate for personalised cancer care in the Eastern Mediterranean Region. Developed with the help and support of IAPO, PhRMA MEA, leading scientists in the field, oncologists and most importantly patients’ organizations and civil societies in the region, the paper is a seminal reference when it comes to personalised cancer care (PCC) with actual patients’ voices being integrated. The way the recommendations were presented in the position paper, they provide a comprehensive road map and a way forward to make sure that personalised cancer care will be accessible to all patients in the Eastern Mediterranean Region, even in low and middle income countries. 

This position paper is the first of its kind to put personalised cancer care in the spotlight of high level policy makers while paving the road for patients’ organizations and civil societies to advocate and lobby for PCC within their own universal health coverage, communities and with policy makers in the WHO Eastern Mediterranean.

This paper sets the baseline for further discussion and development of personalised cancer care within our health systems and regions to ensure we have a predictive, preventative, participatory, personalised and pre-emptive cancer care.

Position Paper - English

Position Paper - Arabic

Call to Action at the The Personalised Cancer Care Alliance Side Event at WHA 76 titled ‘Amana upon our shoulders – Call to adoption and integration of personalised cancer care in the WHO Eastern Mediterranean Region’